Reply: GDNF poses troubling questions for doctors, drug maker [3]

John T. Slevin, Greg A. Gerhardt, Charles D. Smith, Don M. Gash, A. Byron Young

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)989-990
Number of pages2
JournalAnnals of Neurology
Volume59
Issue number6
DOIs
StatePublished - Jun 2006

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Reply: GDNF poses troubling questions for doctors, drug maker [3]'. Together they form a unique fingerprint.

Cite this